Why Big Pharma is chasing the industry’s most-powerful supercomputer
Bristol Myers Squibb is the latest major drugmaker to tap Nvidia for more computing power, betting that larger models and AI agents can speed drug discovery.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.
